Friday, July 31, 2026

Tariffs 15% to 25%: Trump Move Heads for the Federal Register as Seoul Scrambles to Pass U.S. Investment Law by Next Month

President Trump's 25% tariff on Korean imports sparks urgent negotiations and political maneuvering in South Korea's National Assembly.

FLEEING TO BEIJING : Kim Jong Un’s Desperate Love Letter To Xi Jinping As U.S. Assassination Threats Mount

Kim Jong Un and Xi Jinping's recent correspondence highlights a strengthening of North Korea-China relations ahead of Trump's China visit.

Tensions Rise as North Korean Propaganda Balloons Found Near South Korean Fire Sites

In the wake of recent provocations involving...

Tag: immuno-oncology

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

GI-101A: Breakthrough Immuno-Oncology Drug Set for ASCO 2026 Presentation

GI Innovation's GI-101A will be presented at ASCO 2026, highlighting its clinical potential and significance in oncology.

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.